Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
The Journal of Experimental Biology
|
June 9, 2005
The aerodynamics of hovering flight in Drosophila
Steven N Fry, Rosalyn Sayaman, Michael H Dickinson
Science (New York, N.Y.)
|
April 19, 2003
The aerodynamics of free-flight maneuvers in Drosophila
Steven N Fry, Rosalyn Sayaman, Michael H Dickinson
Plos Biology
|
November 5, 2024
Transcriptomic analysis of the 12 major human breast cell types reveals mechanisms of cell and tissue function
Katelyn Del Toro, Rosalyn Sayaman, Kate Thi, et al.
Breast Cancer Research and Treatment
|
January 28, 2026
Breast cancer risk level and prediction of tumor aggressiveness in the Athena Breast Health Network
Katherine Leggat-Barr, Tomiyuri Lewis, Jeffrey A Tice, et al.
JCO Precision Oncology
|
June 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial
Denise M Wolf, Christina Yau, Michael Campbell, et al.
Cancer Cell
|
May 27, 2022
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
Denise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
The Journal of Experimental Biology
|
June 9, 2005
The aerodynamics of hovering flight in Drosophila
Steven N Fry, Rosalyn Sayaman, Michael H Dickinson
Science (New York, N.Y.)
|
April 19, 2003
The aerodynamics of free-flight maneuvers in Drosophila
Steven N Fry, Rosalyn Sayaman, Michael H Dickinson
Plos Biology
|
November 5, 2024
Transcriptomic analysis of the 12 major human breast cell types reveals mechanisms of cell and tissue function
Katelyn Del Toro, Rosalyn Sayaman, Kate Thi, et al.
Breast Cancer Research and Treatment
|
January 28, 2026
Breast cancer risk level and prediction of tumor aggressiveness in the Athena Breast Health Network
Katherine Leggat-Barr, Tomiyuri Lewis, Jeffrey A Tice, et al.
JCO Precision Oncology
|
June 17, 2025
Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial
Denise M Wolf, Christina Yau, Michael Campbell, et al.
Cancer Cell
|
May 27, 2022
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies
Denise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
Page
of 1